Jeffrey is an intellectual property attorney with more than 30 years of US and international experience, including work at a law firm, four multi-national corporations, and three startup companies. He has special skills related to regulatory issues for branded and generic pharmaceuticals patent certifications, patent term extensions, generic exclusivity, and pharmaceutical life-cycle management strategies. Jeffrey’s principal role in Daya are:
- Lead efforts in establishing company structure and global IP position.
- Lead efforts to frame regulatory strategy of the company.
- Review strategic approaches to add and protect company’s intellectual property.